The Sanford Guide to Antimicrobial Therapy 2022 - David N. Gilbert, Henry F. Chambers, Michael S. Saag | Consegna Gratis
18app attiva! I Acquista i tuoi primi libri universitari con il buono 18app. Hai tempo fino al 28 febbraio 2023 Scopri di più

The Sanford Guide to Antimicrobial Therapy 2022

novità
The Sanford Guide to Antimicrobial Therapy 2022
titolo The Sanford Guide to Antimicrobial Therapy 2022
Autori , ,
argomenti
Editore Sanford
Formato Libro: Pocket edition 11,1 x 16,5 cm
Lingua inglese
Pubblicazione 2022
Numero edizione 52
ISBN 9781944272197
18app Carta del docente Acquistabile con bonus 18app o Carta del docente
 
40,00
 
Disponibilità immediata
Spese di spedizione gratis
The 52nd edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, The Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians, The Sanford Guide to Antimicrobial Therapy provides information that is convenient, concise, and reliable. 
This year's guide includes a FREE 1-month trial of Sanford Guide All Access, which provides expanded content, interactive tables and tools, updated daily, for mobile apps and the web.

NOTICE: This year's guide is printed on thicker off-white paper due to supply chain issues.

Available in print in pocket size, spiral bound and large library editions. 

Coverage includes:

  • Clinical syndromes
    • pathogens
    • bacterial
    • fungal
    • mycobacterial
    • parasitic
    • viral
  • Anti-infective agents
    • dosing
      • pediatric adjustments
      • renal adjustments
    • adverse effects
    • activity
    • pharmacology
    • interactions
  • Preventative therapy

What's new in 2022:
Numerous changes throughout, with major changes in the following areas:
  • New Drugs - Addition of new COVID-19 drugs, cefiderocol, ibrexafungerp, brincidofovir, cabotegravir, doravirine, and more.
  • New Tables - ECMO Drug Dosing Adjustment (Table 10F) and QTc Prolongation (Table 10G).
  • Table 1: Initial Choice of Antimicrobial Therapy - Numerous changes including 2021 CDC STI updates, recommendations for resistant infections.
  • Table 5: Recommendations for MDR Bacteria - Updates for gram-negative bacilli updated based on recent evidence and IDSA Guidelines.
  • Table 12: Treatment of Mycobacterial Infections - Revised recommendations for latent M. tuberculosis & non-tuberculous mycobacteria.
  • Table 13: Treatment of Parasitic Infections - Significant changes to amebic meningoencephalitis, babesiosis and trypanosomiasis, and updates to sources for antiparasitic drugs (Table 13D).
  • Table 14: Treatment of Viral Infections - Updates to COVID-19 treatment recommendations (digital subscriptions have most recent updates)
 

Inserire il codice per il download.

Inserire il codice per attivare il servizio.